A qualitative study exploring the reason for low dosage of methadone prescribed in the MMT clinics in China

Drug and Alcohol Dependence

Volumn 117, Issue 1, 2011, Pages 45-49

  Lin, Chunqing ^a   Detels, Roger ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

China; Dosage; Methadone maintenance therapy; Opioid use; Qualitative study

Indexed keywords

METHADONE;

ADMINISTRATIVE PERSONNEL; ADULT; AGED; ARTICLE; CHINA; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG OVERDOSE; FEMALE; HARM REDUCTION; HEALTH CARE DELIVERY; HEALTH CARE SURVEY; HUMAN; INTERPERSONAL COMMUNICATION; LONG TERM CARE; LOW DRUG DOSE; MALE; MEDICAL EDUCATION; MEDICAL LIABILITY; METHADONE TREATMENT; NURSE; OPIATE ADDICTION; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUALITATIVE RESEARCH; TREATMENT DURATION;

ADULT; AMBULATORY CARE FACILITIES; CHINA; FEMALE; HEALTH COMMUNICATION; HEROIN DEPENDENCE; HUMANS; INTERVIEW, PSYCHOLOGICAL; LIABILITY, LEGAL; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; OVERDOSE; PROFESSIONAL-PATIENT RELATIONS; QUALITATIVE RESEARCH; SUBSTANCE ABUSE TREATMENT CENTERS; TREATMENT OUTCOME;

EID: 79959656491     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.01.004     Document Type: Article

References (34)

1. Amato L., Davoli M.A., Perucci C., Ferri M., Faggiano F.P., Mattick R. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J. Subst. Abuse Treat. 2005, 28:321-329.
2. Bao Y., Liu Z., Epstein D.H., Du C., Shi J., Lu L. A meta-analysis of retention in methadone maintenance by dose and dosing strategy. Am. J. Drug Alcohol Abuse 2009, 35:28-33.
3. Brislin R.W. Back translation for cross-cultural research. J. Cross Cult. Psychol. 1970, 1:185-216.
4. Dole V.P., Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride. JAMA 1965, 193:80-84.
5. Faggiano F., Vigna-Taglianti F., Versino E., Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst. Rev. 2003, 3:CD002208.
6. Flynn P.M., Joe G.W., Broome K.W., Simpson D.D., Brown B.S. Looking back on cocaine dependence: reasons for recovery. Am. J. Addict. 2003, 12:398-411.
7. Glaser B.G., Strauss A.L. The Discovery of Grounded Theory: Strategies for Qualitative Research 1967, Aldine de Gruyter, New York.
8. Gossp M., Trakada K., Steward D., Witton J. Reduction in criminal convictions after addiction treatment: 5-year follow-up. Drug Alcohol Depend. 2005, 79:295-302.
9. Johnson R.E., Chutuape M.A., Strain E.C., Walsh S.L., Stitzer M.L., Bigelow G.E. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N. Engl. J. Med. 2000, 343:1290-1297.
10. Joseph H., Stancliff S., Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt. Sinai J. Med. 2000, 67:347-364.
11. Kimber J., Dolan K., Wodak A. Survey of drug consumption rooms: service delivery and perceived public health and amenity impact. Drug Alcohol Rev. 2005, 24:21-24.
12. Leavitt S.B., Shinderman M., Maxwell S., Eap C.B., Paris P. When "enough" is not enough: new perspectives on optimal methadone maintenance dose. Mt. Sinai J. Med. 2000, 67:404-411.
13. Ling W., Wesson D.R., Charuvastra C., Klett C.J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch. Gen. Psychiatry 1996, 53:401-407.
14. Lin C., Wu Z., Rou K., Yin W., Wang C., Shoptaw S., Detels R. Structural-level factors affecting implementation of the methadone maintenance therapy program in China. J. Subst. Abuse Treat. 2010, 38:119-127.
15. Lin C., Wu Z., Rou K., Pang L., Cao X., Shoptaw S., Detels R. Challenges in providing services in methadone maintenance therapy clinics in China: service providers' perceptions. Int. J. Drug Policy 2010, 21:173-178.
16. Lin, C., 2009. Factors Associated with Successful Implementation of the Methadone Maintenance Therapy (MMT) Programs in China (Doctoral Dissertation). University of California, Los Angeles. CA.
17. Liu E., Liang T., Shen L., Zhong H., Wang B., Wu Z., Detels R. Correlates of methadone client retention: a prospective cohort study in Guizhou province, China. Int. J. Drug Policy 2009, 20:304-308.
18. Loughlin A.M., Schwarts R., Strathdee S.A. Prevalence and correlates of HCV infections among methadone treatment attendees: implications for HCV treatment. Int. J. Drug Policy 2004, 15:93-101.
19. Metzger D.S., Woody G.E., McLellan A.T., O'Brien C.P., Druley P., Navaline H., DePhilippis D., Stolley P., Abrutyn E. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J. Acquir. Immune Defic. Syndr. 1993, 6:1049-1056.
20. Ministry of Health of China (MOH), Ministry of Public Security of China, and State Food and Drug Administration (SFDA), 2006. Work Plan of Community Maintenance Treatment for Opioid Addicts. (accessed 28.12.10.). http://www.chinaaids.cn/worknet/download/2005/0308.doc.
21. Muhr T. Atlas. TI [Computer Software] 1997, Scientific Software Development, Berlin.
22. NIH Consensus Conference Effective medical treatment of opiate addiction. JAMA 1998, 280:1936-1943.
23. Pang L., Hao Y., Mi G.D., Wang C.H., Luo W., Rou K.M., Li J., Wu Z. Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS 2007, 21:S103-S107.
24. Peterson J.A., Schwartz R.P., Mitchell S.G., Reisinger H.S., Kelly S.M., O'Grady K.E., Brown B.S., Agar M.H. Why don't out-of-treatment individuals enter methadone treatment programmes?. Int. J. Drug Policy 2010, 21:36-42.
25. Preston K.L., Umbricht A., Epstein D.H. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Arch. Gen. Psychiatry 2000, 57:395-404.
26. Sandelowski M. The problem of rigor in qualitative research. ANS. Adv. Nurs. Sci. 1986, 8:27-37.
27. Strain E.C., Bigelow G.E., Liebson I.A., Stitzer M.L. Moderate- vs. highdose methadone in the treatment of opioid dependence: a randomized trial. JAMA 1999, 281:1000-1005.
28. Sullivan G.S., Wu Z. Rapid scale up of harm reduction in China. Int. J. Drug Policy 2007, 18:118-128.
29. The People's Government of Jiangxi Province, 2010. Jiangxi's GDP Exceeds RMB700b in 2009. (accessed 28.12.10.). http://english.jiangxi.gov.cn/ForInvestment/InvestmentEnvironment/201003/t20100305_202175.htm.
30. The People's Government of Zhejiang Province, 2010. Statistical Bulletin of National Economic and Social Development in Zhejiang Province 2009. (accessed 28.12.10.). http://www.zhejiang.gov.cn/gb/zjnew/node3/node22/node168/node370/node381/userobject9ai113454.html.
31. Thiede H., Hagan H., Murrill C.S. Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. J. Urban Health 2000, 77:331-345.
32. Trafton J.A., Minkel J., Humphreys K. Determining effective methadone doses for individual opioid-dependent patients. PLoS Med. 2006, 3:1549-1676.
33. Ward J., Hall W., Mattick R.P. Role of maintenance treatment in opioid dependence. Lancet 1999, 353:221-226.
34. Yin W., Hao Y., Sun X., Gong X., Li F., Li J., Rou K., Sullivan S.G., Wang C., Cao X., Luo W., Wu Z. Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int. J. Epidemiol. 2010, 39:29-37.